{"id":"W4365517174","doi":"10.1016/s1473-3099(23)00047-6","title":"Redefining Clostridioides difficile infection antibiotic response and clinical outcomes","year":2023,"lang":"en","type":"review","venue":"The Lancet Infectious Diseases","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Universitätsklinikum Heidelberg; Falk Foundation; Universitätsklinikum Köln; Astellas Pharma; Nabriva Therapeutics; Seres Therapeutics; European Tissue Symposium; Idorsia Pharmaceuticals; European Federation of Pharmaceutical Industries and Associations; GlaxoSmithKline; Pfizer; Gilead Sciences; Da Volterra; U.S. Department of Veterans Affairs","keywords":"Clostridioides; Medicine; Antibiotics; Clinical endpoint; Internal medicine; Day treatment; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001717987,0.000759745,0.003811319,0.0005190278,0.0004868762,0.0002253683,0.0002884963,0.0005210454,0.00005794465],"category_scores_gemma":[0.006613917,0.0004709159,0.001428633,0.001146639,0.0005311938,0.00007135386,0.000474132,0.001556757,0.0006168887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003517464,"about_ca_system_score_gemma":0.0009031952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002471017,"about_ca_topic_score_gemma":0.0000476618,"domain_scores_codex":[0.9949609,0.001339374,0.00125591,0.0009100116,0.0006514636,0.0008823149],"domain_scores_gemma":[0.9918064,0.005785234,0.0004827471,0.001335114,0.0001491323,0.0004414041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001142051,0.00103337,0.1261677,0.0219838,0.003610984,0.0004734925,0.00004463325,0.000002667408,0.000003898301,0.0001721643,0.01487257,0.8304927],"study_design_scores_gemma":[0.002915871,0.001443574,0.08759059,0.01525917,0.009977272,0.0006006582,0.00004006461,0.00002655825,0.000007367343,0.00009320032,0.88107,0.0009756872],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1115547,0.8830881,0.000002027974,0.0004819038,0.0007478047,0.001874337,0.0004099565,0.001119976,0.0007212107],"genre_scores_gemma":[0.01176708,0.984768,0.000004426718,0.0001797003,0.001792399,0.0001152185,0.0002120243,0.0001900986,0.0009711084],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8661974,"threshold_uncertainty_score":0.9997743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1410203808154763,"score_gpt":0.4354129077907551,"score_spread":0.2943925269752788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}